Richard D. Press, M.D., Ph.D.

Director, Molecular Pathology and Molecular Diagnostics Laboratories,

Knight Diagnostic Laboratories, Oregon Health & Science University

Professor of Pathology, OHSU

Biographical Sketch

Dr. Press received his M.D.and Ph.D. from Case Western Reserve University in Cleveland, Ohio.  He completed his pathology and molecular pathology residencies at the University of Pennslyvania.   Dr. Press is board-certified in Clinical Pathology and Molecular Genetic Pathology. 

Dr. Press is the program director for the Molecular Genetic Pathology Fellowship. His research interests include molecular diagnostic biomarkers in cancer, infectious diseases and prevalent genetic alterations in common diseases. He has authored or co-authored more than 90 publications.

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More